SAM
PFE icon

Scotia Asset Management’s Pfizer PFE Stock Holding History

Scotia Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$12.9M Buy
473,521
+33,763
+8% +$919K 0.64% 29
2013
Q2 		$11.7M Buy
+439,758
New +$12.2M 0.62% 32

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Scotia Asset Management's PFE Position: Q3 2013 in Review

Scotia Asset Management increased its Pfizer (PFE) stake by 7.7% in Q3 2013, buying an estimated $919K and bringing the position to 473,521 shares worth $12.9M. The position accounts for 0.64% of the portfolio, ranked #29.

Scotia Asset Management first reported a position in PFE in Q2 2013 and has held it in 2 quarters since. 1,605 funds tracked by Wall St. Rank hold PFE as of Q3 2013.

  • Scotia Asset Management held 473,521 shares of Pfizer worth $12.9M as of Q3 2013.
  • Scotia Asset Management bought 33,763 Pfizer shares in Q3 2013, an estimated $919K.
  • Pfizer made up 0.64% of Scotia Asset Management's portfolio in Q3 2013, its #29 holding.
  • Scotia Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 2 quarters since.
  • 1,605 funds tracked by Wall St. Rank held Pfizer as of Q3 2013.

Based on Scotia Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.